NIH Global Health Funding

In addition to Fogarty-supported programs and the trans-NIH programs and collaborations Fogarty is involved in, many Institutes and Centers at NIH offer funding opportunities to support research on global health topics, or in areas relevant to global health.

Current global health funding opportunities from across NIH

Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) (PAR-18-335)
Expiration Date: August 1, 2020
U.S.-India Collaborative Environmental Health Research Program (R01 Clinical Trial Optional) (RFA-ES-20-010)
Expiration Date: October 16, 2020
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional) (PAR-18-801) and (R41/R42 - Clinical Trial Optional) (PAR-18-802)
Expiration Date: January 6, 2021
International Research Collaboration on Drug Abuse and Addiction Research (R01 - Clinical Trial Optional) (PA-18-773)
Expiration Date: May 8, 2021
Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed) (RFA-CA-20-031)
Expiration Date: June 25, 2021
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed) (PAR-19-258)
Expiration Date: September 8, 2021
Co-infection and Cancer (R01 Clinical Trial Not Allowed) (PAR-20-062) and (R21 Clinical Trial Not Allowed) (PAR-20-061)
Expiration Date: January 8, 2023
Notice of Special Interest (NOSI): Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (NOT-CA-20-022)
Applies to due dates on or after May 7, 2020, and subsequent receipt dates through January 8, 2023.

Other NIH global health funding resources

Updated May 4, 2020